AdaptHealth [AHCO] vs Abbott Laboratories [ABT] Detailed Stock Comparison

AdaptHealth Corp.

NASDAQ
Loading...

Abbott Laboratories

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: AdaptHealth Corp. wins in 7 metrics, Abbott Laboratories wins in 12 metrics, with 0 ties. Abbott Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric AdaptHealth Corp. Abbott Laboratories Better
P/E Ratio (TTM) 16.64 25.97 AdaptHealth Corp.
Price-to-Book Ratio 1.11 3.09 AdaptHealth Corp.
Debt-to-Equity Ratio 124.67 26.79 Abbott Laboratories
PEG Ratio -0.05 -1.41 AdaptHealth Corp.
EV/EBITDA 6.03 13.74 AdaptHealth Corp.
Profit Margin (TTM) -2.18% 13.90% Abbott Laboratories
Operating Margin (TTM) 6.20% 16.50% Abbott Laboratories
EBITDA Margin (TTM) 6.20% 16.50% Abbott Laboratories
Return on Equity -4.25% 12.36% Abbott Laboratories
Return on Assets (TTM) 2.91% 7.52% Abbott Laboratories
Free Cash Flow (TTM) $219.38M $7.40B Abbott Laboratories
Dividend Yield N/A 1.97% N/A
1-Year Return 18.14% -34.98% AdaptHealth Corp.
Price-to-Sales Ratio (TTM) 0.53 3.57 AdaptHealth Corp.
Enterprise Value $3.53B $166.96B Abbott Laboratories
EV/Revenue Ratio 1.09 3.70 AdaptHealth Corp.
Gross Profit Margin (TTM) 54.14% N/A N/A
Revenue per Share (TTM) $24 $26 Abbott Laboratories
Earnings per Share (Diluted) $-0.52 $3.57 Abbott Laboratories
Beta (Stock Volatility) 1.50 0.78 Abbott Laboratories
Short % of Float 7.98% 1.53% Abbott Laboratories

AdaptHealth Corp. vs Abbott Laboratories Stock Performance Analysis

Loading Price Chart...

AHCO
ABT

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
AdaptHealth Corp.0.55%7.24%7.35%-13.43%5.38%13.34%
Abbott Laboratories0.56%-2.02%4.97%-19.35%-30.98%-28.60%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
AdaptHealth Corp.18.14%0.59%-63.29%4.74%4.74%4.74%
Abbott Laboratories-34.98%-16.97%-20.08%135.84%255.56%329.52%

Performance & Financial Health Analysis: AdaptHealth Corp. vs Abbott Laboratories

MetricAHCOABT
Market Information
Market Cap i$1.73B$160.70B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i1,287,21113,495,583
90 Day Avg. Volume i1,413,66712,934,461
Last Close$10.96$88.67
52 Week Range$8.51 - $13.43$81.97 - $139.06
% from 52W High-18.39%-36.24%
All-Time High$41.58 (Feb 01, 2021)$142.60 (Dec 27, 2021)
% from All-Time High-73.64%-37.82%
Growth Metrics
Quarterly Revenue Growth-0.01%0.08%
Quarterly Earnings Growth0.00%-0.19%
Financial Health
Profit Margin (TTM) i-0.02%0.14%
Operating Margin (TTM) i0.06%0.17%
Return on Equity (TTM) i-0.04%0.12%
Debt to Equity (MRQ) i124.6726.79
Cash & Liquidity
Book Value per Share (MRQ)$11.46$30.02
Cash per Share (MRQ)$0.78$5.14
Operating Cash Flow (TTM) i$601.77M$10.80B
Levered Free Cash Flow (TTM) i$246.52M$13.77B
Dividends
Last 12-Month Dividend Yield iN/A1.97%
Last 12-Month Dividend iN/A$2.40

Valuation & Enterprise Metrics Analysis: AdaptHealth Corp. vs Abbott Laboratories

MetricAHCO (Apr 24, 2026)ABT (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i16.6425.97
Forward P/E i10.1415.29
PEG Ratio i-0.05-1.41
Price to Sales (TTM) i0.533.57
Price to Book (MRQ) i1.113.09
Market Capitalization
Market Capitalization i$1.73B$160.70B
Enterprise Value i$3.53B$166.96B
Enterprise Value Metrics
Enterprise to Revenue i1.093.70
Enterprise to EBITDA i6.0313.74
Risk & Other Metrics
Beta i1.500.78
Book Value per Share (MRQ) i$11.46$30.02

Financial Statements Comparison: AdaptHealth Corp. vs Abbott Laboratories

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricAHCO (2025)ABT (2025)
Revenue/Sales i3.24B44.33B
Cost of Goods Sold i2.64B19.32B
COGS % of Revenue i81.2%43.6%
Gross Profit i609.20M25.01B
Gross Margin i18.8%56.4%
Research & Development iN/A2.94B
Operating Income (EBIT) i186.27M8.05B
Operating Margin i5.7%18.2%
EBITDA i567.92M12.03B
EBITDA Margin i17.5%27.1%
Pre-Tax Income i-15.15M8.47B
Pre-Tax Income % of Revenue i-0.5%19.1%
Income Tax i50.88M1.94B
Income Tax % of Revenue i1.6%4.4%
Net Income (Profit) i-66.04M6.52B
Profit Margin i-2.0%14.7%

Balance Sheet & Liquidity Metrics

MetricAHCO (2025)ABT (2025)
Cash & Equivalents i106.14M8.52B
Total Current Assets i728.90M26.00B
Total Current Assets % of Revenue i22.5%58.6%
Total Current Liabilities i712.39M16.50B
Total Current Liabilities % of Revenue i22.0%37.2%
Long-Term Debt i1.83B10.83B
Long-Term Debt % of Revenue i56.5%24.4%
Total Shareholders Equity i1.53B52.77B
Retained Earnings i-632.97M49.78B
Retained Earnings % of Revenue i-19.5%112.3%
Property, Plant & Equipment i1.11B17.57B

Cash Flow Statement Comparison

MetricAHCO (2025)ABT (2025)
Operating Cash Flow i567.45M10.80B
Operating Cash Flow % of Revenue i17.5%24.4%
Capital Expenditures i-382.39M-2.17B
Free Cash Flow i219.38M7.40B
FCF Margin i6.8%16.7%
Debt Repayment i-268.48M-1.50B
Common Stock Repurchase i0-893.00M

Short Interest & Institutional Ownership Analysis

MetricAHCOABT
Shares Short i8.32M23.83M
Short Ratio i4.891.93
Short % of Float i7.98%1.53%
Shares Outstanding i132.52M1.74B
Float Shares i88.38M1.73B
% Held by Insiders i2.94%0.54%
% Held by Institutions i108.99%82.23%
% Held by Public i-11.93%17.23%

Dividend Analysis & Yield Comparison: AdaptHealth Corp. vs Abbott Laboratories

MetricAHCOABT
Last 12-Month Dividend iN/A$2.40
Last 12-Month Dividend Yield iN/A1.97%
3-Year Avg Annual Dividend iN/A$2.24
3-Year Avg Dividend Yield iN/A0.50%
3-Year Total Dividends iN/A$6.72
Ex-Dividend DateN/AJan 15, 2026